29 May, 2026

Eli Lilly to acquire three small vaccine developers

Andrew covers the biopharmaceutical industry, scientific research and public health across the continent. You can reach Andrew confidentially on Signal at drawqjoseph.71. Eli Lilly announced Tuesday that it would buy three early- and mid-stage vaccine developers, giving the field a boost. The deals — which together could cost nearly $4 billion — are the latest […]

2 mins read

Moderna’s key CMV vaccine study, expected to be the next big win, failed

Moderna said Wednesday afternoon that its experimental vaccine against cytomegalovirus, a cause of disability in newborns, had failed in a Phase 3 trial, a significant setback for a company already facing pressure from Wall Street and the federal government. The CMV vaccine was the company’s main program before the Covid-19 pandemic. Executives have repeatedly said […]

1 min read

The FDA approves the Novavax coverage vaccine after delay

Helen Branswell covers questions largely linked to infectious diseases, including epidemics, preparation, research and the development of vaccines. Follow it on Mastodon and Bluesky. You can reach Helen on signal at Hbranswell.01. The Food and Drug Administration finally approved the COVVI-19 Novavax vaccine, but in doing so, this imposed restrictions on its two competitors on […]

1 min read